Loading…
Loading…
EQUITY / NASDAQ · XNAS
BIO-key International, Inc.
01 / RESEARCH
8 financial reports are available for research.
Start research ↗2.7 USD · -3.5714%
Observed: Oct 1, 2026, 10:49 AM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
09/30/2026 · 2.8 USD · Volume 2,153,460
62 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Cash and cash equivalents | 1,379,300 USD | — | — |
| Gross profit | 1,674,040 USD | 1,232,727 USD | +35.80% |
| Net income | -576,852 USD | -1,167,396 USD | — |
| Operating profit | -529,405 USD | -1,083,850 USD | — |
| Total assets | 7,483,076 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD | 2025 / Year endConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 1,379,300 USD | — | — | 2,694,663 USD | 2,694,663 USD | 2,039,853 USD | — | — |
| Gross profitIncome statement | 1,674,040 USD | 3,443,273 USD | — | — | 4,564,518 USD | 1,191,718 USD | 3,752,106 USD | 1,232,727 USD |
| Net incomeIncome statement | -576,852 USD | -781,889 USD | -205,037 USD | — | -7,157,946 USD | -964,849 USD | -2,868,790 USD | -1,167,396 USD |
| Operating profitIncome statement | -529,405 USD | -687,119 USD | — | — | -6,827,607 USD | -892,190 USD | -2,616,678 USD | -1,083,850 USD |
| Total assetsBalance sheet | 7,483,076 USD | — | — | 8,303,315 USD | 8,303,315 USD | 10,113,313 USD | — | — |
| Total equityBalance sheet | 4,334,878 USD | — | 4,892,013 USD | 5,106,805 USD | 5,106,805 USD | 6,045,078 USD | — | 6,852,178 USD |
| Total liabilitiesBalance sheet | 3,148,198 USD | — | — | 3,196,510 USD | 3,196,510 USD | 4,068,235 USD | — | — |
| Capital expendituresCash flow statement | — | 0 USD | — | — | 12,012 USD | — | 7,373 USD | — |
| Financing cash flowCash flow statement | — | -30,519 USD | — | — | 6,912,247 USD | — | 4,456,013 USD | — |
| Investing cash flowCash flow statement | — | 0 USD | — | — | -12,012 USD | — | -7,373 USD | — |
| Operating cash flowCash flow statement | — | -1,203,750 USD | — | — | -4,668,689 USD | — | -2,838,088 USD | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 06/12/2026 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 08/13/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.